AIDS@40: Stories of hope and heroes
The people and the science devoted to stopping HIV Álex Cámara / Getty Images
June 5, 2021, will mark 40 years since Los Angeles physician Dr. Michael Gottlieb and colleagues published the first medical account of what would eventually become known as AIDS. It was a short summary in the Centers for Disease Control and Prevention’s printed weekly newsletter of five cases of pneumonia in gay men, all of whom eventually died. The global story that has unfolded since is an unspeakable tragedy. HIV/AIDS has claimed more than 32.7 million lives, dwarfing the toll of the current COVID-19 pandemic.
VIH, la pandemia olvidada
reporteindigo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reporteindigo.com Daily Mail and Mail on Sunday newspapers.
Community engagement in HIV trials guides equity for COVID-19 vaccine studies
New study highlights longstanding barriers to diversity in prior decade of vaccine trials, despite federal guidelines February 19, 2021 • By Sabin Russell / Fred Hutch News Service The Tampa, Florida-based Bible-Based Fellowship Church encouraged members of the African American community to receive COVID-19 vaccines, organizing clinics in partnership with the county health department. Photo by Octavio Jones / Getty Images
Editor s update: On March 31, the New England Journal of Medicine published an editorial co-authored by Andrasik about addressing vaccine hesitancy in communities of color and the efforts of the COVID-19 Prevention Network.
For more than a decade, psychologist Dr. Michele Andrasik has been working in Seattle on ways to increase opportunities for underrepresented minorities at risk for HIV to participate in clinical trials
Updated Feb 19, 2021 | 10:31 IST
By using state-of-art computational techniques, researchers have uncovered vital data that can be used for the design of more efficacious drugs to treat HIV/AIDS. Researchers find ways to make drug for HIV/AIDS more effective | Photo Credit: iStock Images
Chennai: Madras researchers are working on a new idea that may help develop effective drugs for treating HIV/AIDS. Using molecular dynamics simulations, the research team have shown that introducing electrostatic interaction sites on potential drug molecules can enhance the efficacy of the antiviral drug against the HIV virus.
According to the researchers, the pressing need for better drugs to combat drug-resistant HIV strains led the team to delve into the molecular structure of protease to identify weak sites that can offer a handle for better inhibitor development. By using state-of-art computational techniques the team has uncovered vital data that can be
vimarsana © 2020. All Rights Reserved.